Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Jul;48(1):79-87.
doi: 10.1046/j.1365-2125.1999.00970.x.

Photoinduced covalent binding of frusemide and frusemide glucuronide to human serum albumin

T Mizuma  1 , A F McDonagh, E T Lin, L Z Benet
Affiliations

Photoinduced covalent binding of frusemide and frusemide glucuronide to human serum albumin

T Mizuma et al. Br J Clin Pharmacol. 1999 Jul.

Abstract

Aims: To study reaction of photoactivated frusemide (F) and F glucuronide (Fgnd metabolite) with human serum albumin in order to find a clue to clarify a mechanism of phototoxic blisters from high frusemide dosage.

Methods: F was exposed to light in the presence of human serum albumin (HSA). HSA treated with this method (TR-HSA) was characterized by fluorescence spectroscopic experiment, alkali treatment and reversible binding experiment.

Results: Less 4-hydroxyl-N-furfuryl-5-sulphamoylanthranilic acid (4HFSA, a photodegradation product of F) was formed in the presence of HSA than in the absence of HSA. A new fluorescence spectrum excited at 320 nm was observed for TR-HSA. Alkali treatment of TR-HSA released 4HFSA. Quenching of the fluorescence due to the lone tryptophan near the warfarin-binding site of HSA was observed in TR-HSA. The reversible binding of F or naproxen to the warfarin-binding site of TR-HSA was less than to that of native HSA. These results indicate the photoactivated F was covalently bound to the warfarin-binding site of HSA. The covalent binding of Fgnd, which is also reversibly bound to the warfarin-binding site of HSA, was also induced by exposure to sunlight. Fgnd was more photoactive than F, indicating that F could be activated by glucuronidation to become a more photoactive compound.

Conclusions: The reactivity of photoactivated F and Fgnd to HSA and/or to other endogenous compounds may cause the phototoxic blisters that result at high F dosage.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pathways of photodegradation and glucuronidation of F.
Figure 2
Figure 2
H.p.l.c. chromatograms of F solution after 6 h irradiation (a) in the absence of HSA and (b) in the presence of HSA.
Figure 3
Figure 3
Comparison of fluorescence spectra of HSA obtained under various conditions. Conditions; (a) 0 h in the absence of F (b) 0 h in the presence of F (c) 8 h in the absence of F and (d) 8 h in the presence of F. Numbers on spectra indicate excitation wavelengths.
Figure 4
Figure 4
H.p.l.c. chromatograms of constituents released from HSA by alkali treatment. (a) HSA irradiated in the absence of F (b) HSA irradiated in the presence of F (c) HSA not irradiated in the presence of F.
Figure 5
Figure 5
Rosenthal plots of the reversible binding of F (a) and Nap (b) to HSA after irradiation in the presence and absence of F for 8 h. Closed squares and open squares indicate the values in the absence of F and the values in the presence of F, respectively. Lines represent the simulation data.
Figure 6
Figure 6
Photodegradation of F and Fgnd by sunlight in the presence of HSA.Conditions: photo-exposure time, 30 min; F and Fgnd concentrations, 500 μm; HSA concentration, 500 μm. Data represent mean±s.e.mean (n=3). An asterisk represents significant difference (P<0.01).
Figure 7
Figure 7
Effect of sunlight on the covalent binding of F and Fgnd to HSA.Conditions: photo-exposure time, 30 min; F and Fgnd concentration, 500 μm; HSA concentration, 500 μm. Data represent mean±s.e.mean (n=3). An asterisk represents significant difference (P<0.01).
Figure 8
Figure 8
Scheme showing the photoinduced covalent binding of F and Fgnd to HSA.
See this image and copyright information in PMC

References

    1. Weiner IM, Mudge GH. Diuretics and other agents employed in the mobilization of edema fluid. In: Gilman AG, Goodman LS, Rall TW, Murad F, editors. The Pharmacological Basis of Therapeutics. Seventh. New York: Macmillan Publishing Company; 1985. pp. 887–907.
    1. Burry JN, Lawrence JR. Phototoxic blisters from high frusemide dosage. Br J Dermatol. 1976;94:495–499. - PubMed
    1. Heydenreich G, Pindborg T, Schmidt H. Bullous dermatosis among patients with chronic renal failure on high dose frusemide. Acta Med Scand. 1977;202:61–64. - PubMed
    1. Moore DE, Sithipitaks VJ. Photolytic degradation of frusemide. J Pharm Pharmacol. 1983;35:489–493. - PubMed
    1. Bundgaard H, Norgaard T, Nielsen NM. Photodegradation and hydrolysis of furosemide and furosemide esters in aqueous solutions. Int J Pharm. 1988;42:217–224.